NIH funds study on patient comliance BioSante completes FDA required studies of LibiGel Leavitt sees room for compromise on SCHIP FDA approves new form of Lamisil Caraco receives tentative FDA approval for generic Zyrtec Eli Lilly updates product labels BI-LO Pharmacies to process Tennessee drug card Teva releases generic Coreg Merck wins Florida liability suit FDA rejects Novartis’ Cox-2 Inhibitor, Prexige First Previous 1798 1799 1800 1801 1802 Next Last